Neukio Biotherapeutics
Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.
Neukio Biotherapeutics is a company in biotechnology based in Asia-Pacific (APAC), founded in 2021.
Its activity falls under biotechnology; the profile below is assembled from public directory data.
Asia-Pacific (APAC) is where the company is located.
It is recorded at the Series_A stage.
Recorded headcount: c_00051_00100 employees.
Total disclosed funding stands at about $90M.
| Sector | Biotechnology |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2021 |
| Employees | c_00051_00100 |
| Stage | series_a |
| Total funding | $90,000,000 |
Website: www.neukio.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account